Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Underlying aetiology of acute intracerebral haemorrhage and associations between outcome measures, findings on initial computed tomography scan and ICH classification systems: an observational historical cohort study.

BMJ open·2026
Same author

Treatment-requiring postpartum depression in mothers with multiple sclerosis: A nationwide cohort study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Expert Opinion on Age-Related Sex Hormone Changes and Hypogonadism in People With Multiple Sclerosis: A Delphi Consensus Program.

Neurology. Clinical practice·2026
Same author

Risk of postpartum infection after cesarean section in women with multiple sclerosis: A population-based cohort study.

Multiple sclerosis and related disorders·2026
Same author

Severe Neurological Disorders in the Greenlandic Population: A Nationwide Register-Based Study.

Brain and behavior·2025
Same author

Thunderclap headache as an initial manifestation of acute aortic dissection: a case report and review of literature.

Frontiers in cardiovascular medicine·2025

Related Experiment Video

Updated: Jun 2, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Suicide attempts in multiple sclerosis.

Elsebeth Nylev Stenager1, Børge Jensen, Maria Stenager

  • 1Department of Psychiatry, Odense and Augustenborg, The Psychiatry of Southern Denmark, Denmark. elsebeth.stenager@psyk.regionsyddanmark.dk

Multiple Sclerosis (Houndmills, Basingstoke, England)
|April 23, 2011
PubMed
Summary
This summary is machine-generated.

This study found no increased risk of suicide attempts in multiple sclerosis (MS) patients compared to the general population. Treatment with immunomodulating therapy also did not affect suicide attempt rates in MS patients.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Related Experiment Videos

Last Updated: Jun 2, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Area of Science:

  • Neurology
  • Psychiatry
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease.
  • Understanding the mental health risks, specifically suicide attempts, in MS patients is crucial for comprehensive care.
  • The impact of immunomodulating therapies on suicide attempt risk in MS is not well-established.

Purpose of the Study:

  • To estimate the risk of suicide attempts in Danish multiple sclerosis (MS) patients.
  • To compare this risk against the background population in the County of Funen, Denmark.
  • To assess if immunomodulating therapy influences the rate of suicide attempts in MS patients.

Main Methods:

  • Utilized linked data from the Danish MS Registry, Danish MS Treatment Registry, and Suicide Attempt Registry.
  • Employed unique personal identification numbers for data linkage.
  • Analyzed data from 404 MS patients.

Main Results:

  • No statistically significant increased risk of suicide attempts was observed in multiple sclerosis (MS) patients compared to the general population.
  • The number of suicide attempts did not differ between MS patients receiving immunomodulating therapy and those who were untreated.
  • Out of 404 MS patients, 15 had a history of suicide attempts.

Conclusions:

  • Multiple sclerosis (MS) diagnosis itself does not appear to elevate suicide attempt risk.
  • Immunomodulating therapies commonly used for MS do not seem to alter the risk of suicide attempts.
  • Further research may explore other contributing factors to suicidal ideation or behavior in MS populations.